Marcelo Blaya

1.0k total citations
15 papers, 82 citations indexed

About

Marcelo Blaya is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Marcelo Blaya has authored 15 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Marcelo Blaya's work include Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Marcelo Blaya is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Marcelo Blaya collaborates with scholars based in United States, Singapore and Lebanon. Marcelo Blaya's co-authors include Nakhle S. Saba, Luis E. Raez, Edgardo S. Santos, Atif Hussein, Gilberto Lopes, Tatiana M. Prowell, M. Catherine Pietanza, Joé U. Levi, Brian C. Boulmay and Gail Walker and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Neurology.

In The Last Decade

Marcelo Blaya

15 papers receiving 82 citations

Peers

Marcelo Blaya

ONCOL

PRM

EPIDE

Jean-Philippe Oster France

Botoul Maqsodi United States

Zsolt Faluhelyi Hungary

Lindsay F. Petersen United States

Ioannis Kotsopoulos United Kingdom

Roberto Di Cicilia Italy

Jasmine C. Huynh United States

Gayle DiLalla United States

C Olier Spain

Jaseela Chiramel United Kingdom

Jean-Philippe Oster France

Marcelo Blaya

32 ×0.9

ONCOL

40 ×1.3

PRM

11 ×0.6

5 ×0.3

8 ×0.7

EPIDE

Citations per year, relative to Marcelo Blaya Marcelo Blaya (= 1×) peers Jean-Philippe Oster

Countries citing papers authored by Marcelo Blaya

Since Specialization

Citations

This map shows the geographic impact of Marcelo Blaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Blaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Blaya more than expected).

Fields of papers citing papers by Marcelo Blaya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcelo Blaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Blaya. The network helps show where Marcelo Blaya may publish in the future.

Co-authorship network of co-authors of Marcelo Blaya

This figure shows the co-authorship network connecting the top 25 collaborators of Marcelo Blaya. A scholar is included among the top collaborators of Marcelo Blaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcelo Blaya. Marcelo Blaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hussein, Atif, et al.. (2024). Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers. International Journal of Molecular Sciences. 25(4). 1973–1973. 17 indexed citations

Boulmay, Brian C., Tatiana M. Prowell, Marcelo Blaya, & M. Catherine Pietanza. (2018). No Decision Is Final: Career Planning and Career Transitions. American Society of Clinical Oncology Educational Book. 38(38). 881–886. 8 indexed citations

Castrellon, Aurelio, et al.. (2017). Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer. Hematology/Oncology and Stem Cell Therapy. 11(1). 30–33. 1 indexed citations

Soares, Heloisa P., Soley Bayraktar, Marcelo Blaya, et al.. (2014). A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere. Cancer Chemotherapy and Pharmacology. 73(4). 839–845. 8 indexed citations

Saba, Nakhle S., et al.. (2013). Cancer of the Indiana Pouch: A Case Report and Review of the Literature. Clinical Genitourinary Cancer. 11(4). e30–e34. 2 indexed citations

Nelson, Amanda E., et al.. (2012). Lumbar Puncture Teaching Module Standardization. Ensuring Patient Safety through Proper Training (P06.024). Neurology. 78(Meeting Abstracts 1). P06.024–P06.024. 1 indexed citations

Blaya, Marcelo & Nakhle S. Saba. (2011). Chemotherapy-Induced Hyperpigmentation of the Tongue. New England Journal of Medicine. 365(10). e20–e20. 13 indexed citations

Velez, Michel, et al.. (2010). Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC. Expert Review of Anticancer Therapy. 10(4). 549–557. 1 indexed citations

Santos, Edgardo S., Marcelo Blaya, & Luis E. Raez. (2009). Gene Expression Profiling and Non–Small-Cell Lung Cancer: Where Are We Now?. Clinical Lung Cancer. 10(3). 168–173. 12 indexed citations

10.

Santos, Edgardo S., Aurelio Castrellon, Marcelo Blaya, & Luis E. Raez. (2008). Controversies in the management of stage IIIA non-small-cell lung cancer. Expert Review of Anticancer Therapy. 8(12). 1913–1929. 4 indexed citations

11.

Calfa, Carmen, G. Lopes, Gail Walker, et al.. (2008). Gemcitabine and oxaliplatin (GEMOX), a promissing combination for the treatment of relapsed, advanced or metastatic non small cell lung cancer (NSCLC). Journal of Clinical Oncology. 26(15_suppl). 19061–19061. 2 indexed citations

12.

Lopes, Gilberto, Alvaro J. Alencar, Marcelo Blaya, et al.. (2007). P2-280: Gemcitabine and Oxaliplatin as second and third line therapy of advanced and metastatic non-small cell lung cancer (NSCLC): evidence of clinical activity and improvement in quality of life.. Journal of Thoracic Oncology. 2(8). S683–S683. 1 indexed citations

13.

Han, Hyo S., Marcelo Blaya, Stefan Glück, et al.. (2007). Dose-dense docetaxel, carboplatinum and trastuzumab (ddTCH) as neoadjuvant therapy for human epidermal receptor 2 (HER2) positive breast cancer. Journal of Clinical Oncology. 25(18_suppl). 11003–11003. 2 indexed citations

14.

Alencar, Alvaro J., Marcelo Blaya, Luis E. Raez, et al.. (2007). Gemcitabine in combination with oxaliplatin as second-line therapy of advanced and metastatic NSCLC. Journal of Clinical Oncology. 25(18_suppl). 18157–18157. 1 indexed citations

15.

Blaya, Marcelo, Gilberto Lopes, Eugene R. Ahn, et al.. (2007). Phase II trial of capecitabine and docetaxel as second line therapy for locally advanced and metastatic pancreatic cancer. Journal of Clinical Oncology. 25(18_suppl). 15029–15029. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact